Monthly Archives: October 2016


BIOMED 2017 in Tel Aviv May 23-25

The 16th BIOMED 2017 Conference and Exhibition will be held May 23-25, 2017 in Tel-Aviv, Israel. As the leading event of Israel’s life sciences industry, Biomed has positioned itself throughout the years as the main annual meeting place for players of Israel’s healthcare industry with their colleagues from around the globe. It presents...
Read more

Alma Crowdfunds for Crohn’s Therapy

Alma is preparing a therapy for testing in patients with Crohn’s Disease.The company plans to conduct the early stage clinical testing. Then, Alma will license the therapy to a larger company and collect royalties from drug sales. </p> Crowdfunding has emerged as a solution and a major opportunity to find...
Read more

BioLineRx Phase 2a for Pancreatic Cancer

BioLineRx Ltd. (NASDAQ/TASE:BLRX) today announced the initiation of a Phase 2a trial investigating BL-8040 in combination with KEYTRUDA® (pembrolizumab), MSD’s anti-PD-1 therapy, in patients with metastatic pancreatic cancer. The Phase 2a study, named the COMBAT study, is an open-label, multicenter, single-arm trial designed to evaluate the safety and efficacy of...
Read more